hemophilus influenzae B, combinations with toxoids

North America

Canada (2)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
ACT-HIB (10MCG+30MCG)/0.5ML kit, powd for sol
Schedule D
im
J07AG51
HIBERIX 10MCG/0.5ML powd for sol
Schedule D
im
J07AG51
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
ACT-HIB (10MCG+30MCG)/0.5ML kit, powd for sol
01959034
HIBERIX 10MCG/0.5ML powd for sol
02239200
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

United States (0)
No result.

Europe

Austria (0)
No result.
Belgium (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
INFANRIX HIB powd & solv for susp for inj
0,5 mL, 1x
0,5 mL, 1x
-
-

im
J07AG51
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
INFANRIX HIB powd & solv for susp for inj
0,5 mL, 1x
0,5 mL, 1x
BE194013
BE193995
-
-
Product
Pack
Ex-fact
Wholesale
Net retail
Gr. retail
Company
INFANRIX HIB powd & solv for susp for inj
0,5 mL, 1x
0,5 mL, 1x
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Bosnia and Herzegovina (0)
No result.
Croatia (0)
No result.
Czechia (0)
No result.
Denmark (0)
No result.
Finland (0)
No result.
Hungary (0)
No result.
Iceland (0)
No result.
Ireland (1)
X
Product
Pack
Market
Pres.
Dosage
ATC
Company
HIBERIX. HAEMOPHILUS TYPE B (HIB) VACCINE. 0.5 ML powd & solv for sol for inj
N
Rx
im
J07AG51
Product
Pack
Reg. Nr.
Reg. Type
Reg. Date
Reg. Valid
Revocation
Company
HIBERIX. HAEMOPHILUS TYPE B (HIB) VACCINE. 0.5 ML powd & solv for sol for inj
PA1077/027/001
11-06-1999
Would you like to in or out-license dossiers? Do you have Marketing Authorization to sell? Would you like to sell or aquire companies? This is the right place for you to find new business opportunities in the pharmaceutical industry.

Lithuania (0)
No result.
Malta (0)
No result.
Netherlands (0)
No result.
Norway (0)
No result.
Poland (0)
No result.
Romania (0)
No result.
Slovenia (0)
No result.
Spain (0)
No result.
Sweden (0)
No result.
Switzerland (0)
No result.